Brief: Evaxion A/S Expands Research And Development Pipeline With New Vaccine Program Targeting Group A Streptococcus
25/06/2025 13:18
June 25 (Reuters) - Evaxion A/S EVAX.O: EVAXION A/S: EXPANDS RESEARCH AND DEVELOPMENT PIPELINE WITH NEW VACCINE PROGRAM TARGETING GROUP A STREPTOCOCCUS EVAXION A/S: NEW VACCINE PROGRAM ADDED TO PIPELINE UNDER NAME EVX-B4 Further company coverage: EVAX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evaxion A/S
See all newsEvaxion A/S reports results for the quarter ended June 30 - Earnings Summary
Denmark's Evaxion Q2 net loss narrows on lower expenses
Brief: Evaxion Q2 Basic EPS USD -0.01
Evaxion A/S expected to post a loss of 31 cents a share - Earnings Preview
Brief: Evaxion A/S - Expands Pipeline Of Cancer Vaccine Programs With Evx-05 Against Brain Cancer Glioblastoma